HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nobumasa Hino Selected Research

KS-133

1/2021Generation of KS-133 as a Novel Bicyclic Peptide with a Potent and Selective VIPR2 Antagonist Activity that Counteracts Cognitive Decline in a Mouse Model of Psychiatric Disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nobumasa Hino Research Topics

Disease

4Inflammation (Inflammations)
01/2021 - 01/2018
2Pathologic Neovascularization
01/2021 - 01/2020
1Cognitive Dysfunction
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Neoplasms (Cancer)
01/2021
1Schizophrenia (Dementia Praecox)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Endotoxemia
01/2018
1Hypersensitivity (Allergy)
07/2014
1Asthma (Bronchial Asthma)
06/2012

Drug/Important Bio-Agent (IBA)

1Pharmaceutical PreparationsIBA
01/2021
1EndotoxinsIBA
01/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1Peptides (Polypeptides)IBA
01/2021
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
01/2021
1KS-133IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019
1Carbonyl Cyanide m-Chlorophenyl Hydrazone (CCCP)IBA
01/2019
1LipopolysaccharidesIBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2018
1ChromatinIBA
07/2014
1Deoxyribonucleases (DNase)FDA Link
07/2014
1Interleukin-5 (Interleukin 5)IBA
06/2012